Clinical trial

EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or…

NCT00107445 · National Cancer Institute (NCI), NIH · Completed

Key facts

NCT number NCT00107445
Title EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer
Official title Evaluation of Hypoxia by EF5 Binding in Gynecologic Cancer
Lead sponsor National Cancer Institute (NCI), NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Primary Peritoneal Cavity Cancer, Stage I Endometrial Carcinoma, Stage I Ovarian Epithelial Cancer, Stage IA Cervical Cancer, Stage IB Cervical Cancer, Stage II Endometrial Carcinoma, Stage II Ovarian Epithelial Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer and 6 more
Intervention type Drug
Interventions EF5
Enrollment 60
Start date Feb 1, 2005
Primary completion Sep 1, 2005
First posted Apr 6, 2005
Last update posted Jan 16, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies